Secobarbital
Back to searchMolecule Structure
Scientific Name
Secobarbital
Description of the Drug
Secobarbital is a barbiturate used for the short-term treatment of insomnia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00418
http://www.drugbank.ca/drugs/DB00418
Brand Name(s)
Seconal
Company Owner(s)
Vitarine Pharmaceuticals Inc, Halsey Drug Co Inc, Kv Pharmaceutical Co, Watson Laboratories Inc, Purepac Pharmaceutical Co, Anabolic Inc, Elkins Sinn Div Ah Robins Co Inc, Wyeth Ayerst Laboratories, Eli Lilly And Co, West Ward Pharmaceutical Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL80734 | ||
| Human Metabolome Database | HMDB0014562 | ||
| DrugBank | DB00418 | ||
| PubChem: Thomson Pharma | 15196371 | ||
| PubChem | 5193 | ||
| Nikkaji | J4.551I | ||
| EPA CompTox Dashboard | DTXSID6044145 | ||
| DrugCentral | 2428 | ||
| Brenda | 94997 | ||
| Guide to Pharmacology | 7615 | ||
| rxnorm | SECOBARBITAL | SECONAL SODIUM | SECOBARBITAL SODIUM |
| ChEBI | 9073 |
